You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

Claims for Patent: 6,977,257


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,977,257
Title: Aripiprazole oral solution
Abstract:The present invention provides for a pharmaceutical solution suitable for oral administration comprising aripiprazole, a pharmaceutically suitable solvent system, one or more taste-enhancing/masking agents and one or more agents selected from the group consisting of lactic acid, acetic acid, tartaric acid and citric acid, wherein said solution has a pH from 2.5 to 4.5.
Inventor(s): Parab; Prakash V. (Monroe Township, NJ), Chou; Joyc Tianw i (Fremont, CA)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:10/131,304
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,977,257
Patent Claims: 1. A pharmaceutical solution suitable for oral administration comprising aripiprazole, a pharmaceutically suitable solvent system comprised of one or more agents selected from the group consisting of water, ethanol, glycerin, propylene glycol and sorbitol, one or more taste-enhancing/masking agents and one or more other agents selected from the group consisting of lactic acid, acetic acid, tartaric acid and citric acid, wherein said solution has a pH from 2.5 to 4.0.

2. A pharmaceutical solution according to claim 1 wherein said other agent is lactic acid.

3. A pharmaceutical solution according to claim 2 wherein said lactic acid is present at concentrations selected from the group of ranges consisting of 0.7 mg/ml to 18 mg/ml, 3.5 mg/ml to 14.5 mg/ml and 5.4 mg/ml to 9 mg.

4. A pharmaceutical solution according to claim 1 wherein aripiprazole is present at concentrations selected from the group of ranges consisting of 0.05 mg/ml to 6 mg/ml, 0.1 mg/ml to 3 mg/ml, 0.25 mg/ml to 2 mg/ml and 0.75 mg/ml to 1.5 mg/ml.

5. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of propylene glycol, glycerin and water each being present in ratios of 0.8-1.2:2.4-3.6:6.4-9.6 w/w respectively.

6. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of glycerin, propylene glycol and water each being present in ratios of 0.8-1.2:2.4-3.6:6.4-9.6 w/w respectively.

7. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of glycerin and water each being present in ratios of 0.8-1.2:6.4-8.6 w/w respectively.

8. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of glycerin and water each being present in ratios of about 1:3 w/w respectively.

9. A pharmaceutical solution according to claim 1 further comprising disodium EDTA.

10. A pharmaceutical solution suitable for oral administration comprising aripiprazole, a pharmaceutically suitable solvent system, one or more taste-enhancing/masking agents and lactic acid, wherein said solution has a pH from 2.5 to 4.5.

11. A pharmaceutical solution according to claim 10 wherein said pharmaceutically suitable solvent system is comprised of one or more agents selected from the group consisting of water, ethanol, glycerin, propylene glycol and sorbitol and wherein said solution has a pH from 2.5 to 4.0.

12. A pharmaceutical solution according to claim 11 wherein one or more of said taste-enhancing/masking agents are selected from the group consisting of flavoring agents, sucrose, fructose, dextrose, maltose, glucose, maltitol, xylitol, sorbitol and mannitol.

13. A pharmaceutical solution suitable for oral administration comprising aripiprazole, glycerin, lactic acid, propylene glycol, methylparaben, propylparaben, sucrose, fructose and water.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.